PEOPLE under 40 will be offered an alternative to the Oxford/AstraZeneca jab over blood clot fears, it was reported tonight.
The Joint Committee of Vaccination and Immunisation (JCVI), a panel of experts which advises the government, is set to announce the guidance on Friday.
It is said to have made the decision out of “an abundance of caution” because rates of Covid are so low in the UK.
The UK-made jab carries a “vanishingly small” risk of causing serious brain clots – around seven in a million.
Experts say the risk is massively outweighed by the jab’s benefits for most people, but for the young and healthy the balance is harder to judge.
The JCVI has already recommended that people younger than 30 are offered the Pfizer or Moderna vaccines instead.